Nanoparticulate adjuvants and delivery systems for allergen immunotherapy (Q26825418)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22496608 AND SRC:MED&resulttype=core&format=json

28 January 2020

3 references

1 June 2020

26 October 2020

11 December 2020

Nanoparticulate adjuvants and delivery systems for allergen immunotherapy (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22496608 AND SRC:MED&resulttype=core&format=json

biomedical investigative technique

28 January 2020

main subject

1 reference

19 September 2019

1 reference

1 October 2019

1 reference

1 reference

1 reference

26 October 2020

1 reference

11 December 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22496608 AND SRC:MED&resulttype=core&format=json

28 January 2020

Juan M. Irache

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22496608 AND SRC:MED&resulttype=core&format=json

28 January 2020

Carlos Gamazo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22496608 AND SRC:MED&resulttype=core&format=json

Juliana De Souza Rebouças

28 January 2020

1

object named as

Juliana De Souza Rebouças

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22496608 AND SRC:MED&resulttype=core&format=json

28 January 2020

2

Irene Esparza

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22496608 AND SRC:MED&resulttype=core&format=json

28 January 2020

author name string

María Luisa Sanz

4

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22496608 AND SRC:MED&resulttype=core&format=json

28 January 2020

language of work or name

1 reference

26 February 2012

7 references

25 June 2019

19 September 2019

1 October 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22496608 AND SRC:MED&resulttype=core&format=json

28 January 2020

1 June 2020

26 October 2020

11 December 2020

Journal of Biomedicine and Biotechnology

8 references

25 June 2019

19 September 2019

1 October 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22496608 AND SRC:MED&resulttype=core&format=json

28 January 2020

1 June 2020

26 October 2020

11 December 2020

2012

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22496608 AND SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

474605

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22496608 AND SRC:MED&resulttype=core&format=json

Creative Commons Attribution 3.0 Unported

28 January 2020

copyright license

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Immunological mechanisms of allergen-specific immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Immunological properties of engineered nanomaterials

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Nanomedicine: novel approaches in human and veterinary therapeutics

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Chitosan nanoparticles: a promising system in novel drug delivery

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

The current state of recombinant allergens for immunotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Chitosan as a carrier for targeted delivery of small interfering RNA

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

CpG oligodeoxynucleotides as TLR9 agonists: therapeutic application in allergy and asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Poly(anhydride) nanoparticles as adjuvants for mucosal vaccination

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Immunomodulation of the allergic inflammatory response: new developments

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Novel immunotherapeutic approaches for allergy and asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Delivery of a peptide via poly(D,L-lactic-co-glycolic) acid nanoparticles enhances its dendritic cell-stimulatory capacity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Role of Treg in immune regulation of allergic diseases.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009.

28 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

28 September 2017

Nanoparticles and the immune system

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

An immunological overview of allergen specific immunotherapy -- subcutaneous and sublingual routes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Silent mysteries: epigenetic paradigms could hold the key to conquering the epidemic of allergy and immune disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Biodegradable polymeric nanoparticles based drug delivery systems

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Therapeutic manipulation of immune tolerance in allergic disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Chitosan micro- and nanospheres: fabrication and applications for drug and DNA delivery.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Mechanisms and treatment of allergic disease in the big picture of regulatory T cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

New insights into the mechanism and management of allergic diseases: atopic dermatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Nanoparticles for nasal vaccination.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Immunomodulatory biomaterials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

The genetic and environmental basis of atopic diseases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Nanotechnology in vaccine delivery

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Discovering susceptibility genes for asthma and allergy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Particle-based vaccines for transcutaneous vaccination

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Chitosan nanoparticles for oral drug and gene delivery

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Peanut allergy: emerging concepts and approaches for an apparent epidemic

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella Enteritidis in mice.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Vaccine adjuvants revisited

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Chitosan-graft-polyethylenimine as a gene carrier

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Sulfated chitin and chitosan as novel biomaterials.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Particulate delivery systems for vaccines: what can we expect?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Biodegradable PLGA particles for improved systemic and mucosal treatment of Type I allergy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Allergen-specific immunotherapy: an update on immunological mechanisms of action

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-linking

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Molecular approaches for new vaccines against allergy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Allergy practice worldwide: a report by the World Allergy Organization Specialty and Training Council

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Bioadhesive properties of pegylated nanoparticles.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Review of novel particulate antigen delivery systems with special focus on treatment of type I allergy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Adjuvants for allergen immunotherapy: experimental results and clinical perspectives

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Formulation aspects of biodegradable polymeric microspheres for antigen delivery

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Recent advances on chitosan-based micro- and nanoparticles in drug delivery

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Mechanisms of immunotherapy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Poly-epsilon-caprolactone microspheres and nanospheres: an overview

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Immunologic influences on allergy and the TH1/TH2 balance

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Noninjection routes for immunotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

From allergen structure to new forms of allergen-specific immunotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Nanocapsule technology: a review.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Chitosans for gene delivery

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Chitosan for mucosal vaccination

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Chitosan as a novel nasal delivery system for vaccines

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Th-2 cytokines in allergic disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Biodegradable polymeric nanoparticles as drug delivery devices

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Analysis of MHC class II presentation of particulate antigens of B lymphocytes.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Production and immunogenicity of hypoallergenic codon-optimized DNA vaccine encoding mature Der p 1 allergen

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Poly(anhydride) nanoparticles act as active Th1 adjuvants through Toll-like receptor exploitation

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-epsilon-caprolactone-based nanoparticles

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Associations between specific serum IgE response and 6 variants within the genes IL4, IL13, and IL4RA in German children: the German Multicenter Atopy Study

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Biodegradable microparticles with different release profiles: effect on the immune response after a single administration via intranasal and intramuscular routes.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303624

Novel cytokine peptide-based vaccines: an interleukin-4 vaccine suppresses airway allergic responses in mice.

31 May 2018

1 reference

Surveillance of systemic reactions to subcutaneous immunotherapy injections: year 1 outcomes of the ACAAI and AAAAI collaborative study

21 January 2018

1 reference

Immunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: Implications for specific immunotherapy

21 January 2018

1 reference

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines

21 January 2018

1 reference

Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery

21 January 2018

1 reference

Allergen-loaded biodegradable poly(D,L-lactic-co-glycolic) acid nanoparticles down-regulate an ongoing Th2 response in the BALB/c mouse model.

21 January 2018

1 reference

Biodegradable poly (DL-lactide glycolide) microparticles as a vehicle for allergen-specific vaccines: a study performed with Ole e 1, the main allergen of olive pollen

21 January 2018

1 reference

Design of biodegradable particles for protein delivery

21 January 2018

1 reference

PLA-PEG particles as nasal protein carriers: the influence of the particle size.

21 January 2018

1 reference

Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles

21 January 2018

1 reference

Influence of reaction medium during synthesis of Gantrez AN 119 nanoparticles for oral vaccination.

21 January 2018

1 reference

Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties

21 January 2018

1 reference

Salmonella-like bioadhesive nanoparticles

21 January 2018

1 reference

A novel nanoparticulate adjuvant for immunotherapy with Lolium perenne.

21 January 2018

1 reference

Development of a novel vaccine delivery system based on Gantrez nanoparticles

21 January 2018

1 reference

Preparation and characterization of biodegradable nanoparticles based on poly(gamma-glutamic acid) with l-phenylalanine as a protein carrier.

21 January 2018

1 reference

Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

21 January 2018

1 reference

The immunologic effect of TGF-beta1 chitosan nanoparticle plasmids on ovalbumin-induced allergic BALB/c mice

21 January 2018

1 reference

Effect of the degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).

21 January 2018

1 reference

Preparation of coated nanoparticles for a new mucosal vaccine delivery system

21 January 2018

1 reference

Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen

21 January 2018

1 reference

Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors

21 January 2018

1 reference

Accelerated immune response to DNA vaccines

21 January 2018

1 reference

Induction of humoral immune response against PfMSP-119 and PvMSP-119 using gold nanoparticles along with alum

21 January 2018

1 reference

Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles

21 January 2018

1 reference

Chitosan-based polyelectrolyte complexes: A review

21 January 2018

1 reference

Gantrez AN nanoparticles as an adjuvant for oral immunotherapy with allergens

21 January 2018

1 reference

Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro

21 January 2018

1 reference

Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles

21 January 2018

1 reference

Induction of cytotoxic T-cell responses following oral immunization with synthetic peptides encapsulated in PLG microparticles

21 January 2018

1 reference

12 December 2020

The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells

1 reference

12 December 2020

Aluminum compounds as vaccine adjuvants

1 reference

12 December 2020

Polyester microparticles as a vaccine delivery system for brucellosis: influence of the polymer on release, phagocytosis and toxicity

1 reference

12 December 2020

Immunization by particle-mediated transfer of the granulocyte-macrophage colony-stimulating factor gene into autologous tumor cells in melanoma or sarcoma patients: report of a phase I/IB study

1 reference

12 December 2020

Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response

1 reference

12 December 2020

[Chitosan-based polyelectrolyte complexes: a review]

1 reference

12 December 2020

Methods for nano-particle based vaccine formulation and evaluation of their immunogenicity

1 reference

12 December 2020

Novel Recombinant Interleukin-13 Peptide-based Vaccine Reduces Airway Allergic Inflammatory Responses in Mice

1 reference

12 December 2020

Polymorphisms in IL13, total IgE, eosinophilia, and asthma exacerbations in childhood

1 reference

12 December 2020

Novel nanoparticles for the delivery of recombinant hepatitis B vaccine

1 reference

12 December 2020

Biodegradable microspheres as a vaccine delivery system

1 reference

12 December 2020

Allergen immunotherapy

1 reference

12 December 2020

N,N'-Carbonyldiimidazole-mediated functionalization of superparamagnetic nanoparticles as vaccine carrier

1 reference

12 December 2020

Altered Expressions of Helper T Cell (Th)1, Th2, and Th17 Cytokines in CD8 and γδ T Cells in Patients with Allergic Asthma

1 reference

12 December 2020

The induction of innate and adaptive immunity by biodegradable poly(γ-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway

1 reference

12 December 2020

Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally

1 reference

12 December 2020

Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators

1 reference

12 December 2020

Liposomes as immunological adjuvants

1 reference

12 December 2020

Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway

1 reference

12 December 2020

Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen

1 reference

12 December 2020

Nasal vaccination: a non-invasive vaccine delivery method that holds great promise for the future

1 reference

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1155/2012/474605

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22496608 AND SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22496608 AND SRC:MED&resulttype=core&format=json

28 January 2020

PubMed publication ID

22496608

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22496608 AND SRC:MED&resulttype=core&format=json